The Use of MIND-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and Other Mental Distress

This six-hour course (recording from the 30th International Trauma Conference) explores the therapeutic potential of psychedelics and cannabis for treating PTSD, anxiety, depression and more.

Learn about revived research into MDMA, psilocybin, and marijuana after decades of prohibition. Discover how psychedelic-assisted psychotherapy facilitates trauma healing, with lasting benefits seen in MAPS-sponsored MDMA trials. Review outcomes from psilocybin studies for cancer patients facing end-of-life distress. Examine the promise and limitations of cannabis for mental health. Gain perspectives from pioneering researchers and clinicians conducting psychedelic therapy.

Through video modules and discussions, develop knowledge of how psychedelics reduce defensive reactions, allowing deeper processing of emotions and memories. Consider how these treatments integrate with contemporary psychotherapy. Earn up to 6 CE credits distinguishing between psychedelics, weighing risks and benefits, and preparing to advise clients about safe, effective psychedelic-assisted healing.